Human papillomavirus (HPV) vaccines have been available and licensed for use in the U.S. among women since 2006 and among men since 2010. Currently, HPV is not a mandatory vaccine for U.S. military service; however, it is encouraged and offered to service members. Between 2007 and 2017, a total of 111,546 (26.6%) eligible active component service women aged 17-26 years and 121,657 (5.8%) men initiated the HPV vaccine. Of those service members who initiated vaccination and remained in service for at least 6 months, less than half of women (46.6%) and only slightly more than one-third of men (35.1%) completed three doses. Initiation and completion rates also varied by service branch, with service members in the Air Force generally having higher initiation and completion rates. The median times between the first and second doses and between the first and third doses were 3.8 months and 10.8 months, respectively. The median time in service at initiation dose was 1.1 years. Continued development and implementation of interventions to enhance HPV vaccination initiation among military service members are warranted.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Knowledge, Attitudes, Perceptions, and Practices Related to Artificial Intelligence in Radiology Among Indian Radiologists and Residents: A Multicenter Nationwide Study.
Cureus
December 2024
Community and Family Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Background Artificial Intelligence (AI) is revolutionizing medical science, with significant implications for radiology. Understanding the knowledge, attitudes, perspectives, and practices of medical professionals and residents related to AI's role in radiology is crucial for effective integration. Methods A cross-sectional survey was conducted among members of the Indian Radiology & Imaging Association (IRIA), targeting practicing radiologists and residents across academic and non-academic institutions.
View Article and Find Full Text PDFCongenital Factor VII Deficiency: A Case Study of Four Family Members.
Cureus
December 2024
Hematology, Avicenna Military Hospital, Marrakesh, MAR.
Congenital factor VII (FVII) deficiency is a rare genetic disorder with autosomal recessive inheritance, characterized by molecular and clinical heterogeneity. This article reports four Moroccan cases of FVII deficiency within the same family, two of which were associated with Gilbert's syndrome. The index case was a 15-year-old girl with a history of menorrhagia and jaundice.
View Article and Find Full Text PDFKnowledge about diabetes in Malmö prior to initiation of "Cities Changing Diabetes".
Front Public Health
January 2025
Faculty of Health and Society, Department of Care Science, Malmö University, Malmö, Sweden.
Aim: To identify existing public knowledge regarding diabetes and diabetes-related services offered to persons living with diabetes in the City of Malmö.
Methods: A literature review of City of Malmö's website, public statistics, School health documentation, job databases, education programs, local newspaper, Swedish National Diabetes Register, and was performed in 2020.
Results: We identified political decisions about diabetes nurses in home care, financing a project about diabetes complications, and funding support in schools for designated children.
Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spending.
BMJ Oncol
January 2024
Medical Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
In the field of general medicine, class effects, or therapeutic interchangeability, have been declared for several families of drugs including statins, calcium channel blockers and ACE inhibitors. The existence of such class effects enables healthcare payers to negotiate for substantially lower drug prices, thereby reducing financial toxicity, both at an individual and societal levels. Until now, the existence of class effects in oncology has been considered rare.
View Article and Find Full Text PDFThe association between the type of bystander and survival after an out-of-hospital cardiac arrest: A French nationwide study.
Resusc Plus
January 2025
Univ. Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des Technologies de santé et des Pratiques Médicales, F-59000 Lille, France.
Background: Early bystander interventions are associated with more favorable outcomes after out-of-hospital cardiac arrest (OHCA). The objective of the present study was to determine whether the type of bystander-patient relationship was associated with survival and neurological outcomes after OHCA in France.
Methods: We analyzed data registered in the French National Cardiac Arrest Registry (RéAC) between July 1st, 2011, and April 30th, 2023.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!